Intrathecal AAV9/AP4M1 gene therapy for hereditary spastic paraplegia 50 shows safety and efficacy in preclinical studies.

Autor: Xin Chen1, Dong, Thomas1, Yuhui Hu1, De Pace, Raffaella2, Mattera, Rafael2, Eberhardt, Kathrin3, Ziegler, Marvin3, Pirovolakis, Terry4, Sahin, Mustafa3, Bonifacino, Juan S.2, Ebrahimi-Fakhari, Darius3, Gray, Steven J.1 Steven.Gray@UTSouthwestern.edu
Zdroj: Journal of Clinical Investigation. 5/15/2023, Vol. 133 Issue 10, p1-16. 16p.
Databáze: Academic Search Ultimate